Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

Journal Scan / Case Study · April 24, 2024

CD19-Targeted CAR T-Cell Therapy in 2 Patients With MS

Med (New York, N.Y.)


Additional Info

Disclosure statements are available on the authors' profiles:

Med (New York, N.Y.)
CD19-targeted chimeric antigen receptor T cell therapy in two patients with multiple sclerosis
Med 2024 Mar 22;[EPub Ahead of Print], F Fischbach, J Richter, LK Pfeffer, B Fehse, SC Berger, S Reinhardt, J Kuhle, A Badbaran, K Rathje, N Gagelmann, D Borie, J Seibel, F Ayuk, MA Friese, C Heesen, N Kröger

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading